187 related articles for article (PubMed ID: 14607835)
1. Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth.
Lynch M; Fitzgerald C; Johnston KA; Wang S; Schmidt EV
J Biol Chem; 2004 Jan; 279(5):3327-39. PubMed ID: 14607835
[TBL] [Abstract][Full Text] [Related]
2. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
Fingar DC; Salama S; Tsou C; Harlow E; Blenis J
Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086
[TBL] [Abstract][Full Text] [Related]
3. The role of c-myc in regulation of translation initiation.
Schmidt EV
Oncogene; 2004 Apr; 23(18):3217-21. PubMed ID: 15094771
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of eukaryotic translation initiation factor 4E and eukaryotic translation initiation factor 4E-binding protein (4EBP) and their upstream signaling components undergo diurnal oscillation in the mouse hippocampus: implications for memory persistence.
Saraf A; Luo J; Morris DR; Storm DR
J Biol Chem; 2014 Jul; 289(29):20129-38. PubMed ID: 24895127
[TBL] [Abstract][Full Text] [Related]
5. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities.
Khaleghpour K; Pyronnet S; Gingras AC; Sonenberg N
Mol Cell Biol; 1999 Jun; 19(6):4302-10. PubMed ID: 10330171
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
7. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers.
Pourdehnad M; Truitt ML; Siddiqi IN; Ducker GS; Shokat KM; Ruggero D
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11988-93. PubMed ID: 23803853
[TBL] [Abstract][Full Text] [Related]
8. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc.
Jones RM; Branda J; Johnston KA; Polymenis M; Gadd M; Rustgi A; Callanan L; Schmidt EV
Mol Cell Biol; 1996 Sep; 16(9):4754-64. PubMed ID: 8756633
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo.
Waskiewicz AJ; Johnson JC; Penn B; Mahalingam M; Kimball SR; Cooper JA
Mol Cell Biol; 1999 Mar; 19(3):1871-80. PubMed ID: 10022874
[TBL] [Abstract][Full Text] [Related]
10. c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation.
Ravitz MJ; Chen L; Lynch M; Schmidt EV
Cancer Res; 2007 Dec; 67(23):11209-17. PubMed ID: 18056446
[TBL] [Abstract][Full Text] [Related]
11. Translational control of programmed cell death: eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc.
Polunovsky VA; Rosenwald IB; Tan AT; White J; Chiang L; Sonenberg N; Bitterman PB
Mol Cell Biol; 1996 Nov; 16(11):6573-81. PubMed ID: 8887686
[TBL] [Abstract][Full Text] [Related]
12. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
13. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.
Dilling MB; Germain GS; Dudkin L; Jayaraman AL; Zhang X; Harwood FC; Houghton PJ
J Biol Chem; 2002 Apr; 277(16):13907-17. PubMed ID: 11847216
[TBL] [Abstract][Full Text] [Related]
14. Ser-64 and Ser-111 in PHAS-I are dispensable for insulin-stimulated dissociation from eIF4E.
Ferguson G; Mothe-Satney I; Lawrence JC
J Biol Chem; 2003 Nov; 278(48):47459-65. PubMed ID: 14507920
[TBL] [Abstract][Full Text] [Related]
15. Ras transformation of RIE-1 cells activates cap-independent translation of ornithine decarboxylase: regulation by the Raf/MEK/ERK and phosphatidylinositol 3-kinase pathways.
Origanti S; Shantz LM
Cancer Res; 2007 May; 67(10):4834-42. PubMed ID: 17510413
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
17. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
Martin D; Nguyen Q; Molinolo A; Gutkind JS
Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
[TBL] [Abstract][Full Text] [Related]
19. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
20. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.
Hsieh AC; Costa M; Zollo O; Davis C; Feldman ME; Testa JR; Meyuhas O; Shokat KM; Ruggero D
Cancer Cell; 2010 Mar; 17(3):249-61. PubMed ID: 20227039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
